tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Income Statement

300 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q3 2026), Neuphoria Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q3, Neuphoria Therapeutics's net income was AU$-505.06K. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 15.65M$ 0.00AU$ 0.00AU$ 383.16KAU$ 927.54K
Gross Profit
$ 14.99M$ -662.99KAU$ -671.48KAU$ -9.98MAU$ -1.27M
Operating Expenses
$ 16.12M$ 17.89MAU$ 33.09MAU$ 23.74MAU$ 11.25M
Depreciation and Amortization
$ 1.01M$ 992.56KAU$ 998.17KAU$ 1.61MAU$ 1.28M
EBITDA
$ -121.90K$ -25.65MAU$ -31.45MAU$ -30.25MAU$ -4.51M
Operating Income
$ -1.13M$ -26.79MAU$ -33.09MAU$ -31.02MAU$ -8.96M
Other Income/Expenses
$ 291.09K$ 2.31MAU$ 695.55KAU$ -886.03KAU$ 2.28M
Pretax Income
$ -838.00K$ -15.58MAU$ -32.39MAU$ -31.90MAU$ -6.68M
Net Income
$ -369.63K$ -15.49MAU$ -32.18MAU$ -22.94MAU$ -6.53M
Per Share Metrics
Basic EPS
$ -0.23$ -0.10AU$ -0.24AU$ -0.20AU$ -0.10
Diluted EPS
$ -0.23$ -0.10AU$ -0.24AU$ -0.20AU$ -0.10
Weighted Average Shares Outstanding
 1.62M 149.80M 122.39M 112.78M 65.00M
Weighted Average Shares Outstanding (Diluted)
 1.62M 149.80M 122.39M 112.78M 65.00M

Neuphoria Therapeutics Earnings and Revenue History